Retatrutide 12 mg produced 24.2% mean body-weight loss at 48 weeks in the Phase 2 obesity trial (Jastreboff et al., NEJM 2023) [3][4]
Genetic testing combined with fresh, monthly-compounded medication ensures your treatment is personalized at both the molecular and pharmaceutical level
Weight-loss jabs such as Wegovy could be made for just $3 a month, according to new analysis, potentially making the treatment available to millions in poorer countries as patents expire
How does this patient differ
If you develop lumps, persistent bruising, or skin changes at injection sites, do not inject into these areas and consult your healthcare provider
Unlike the natural GLP-1 hormone, semaglutide is a modified analog with non-natural amino acid substitutions at positions 7 and/or 8, which improve its stability and resistance to enzymatic breakdown